OBI Pharma (4174) — Working Capital to Net Assets Ratio
OBI Pharma (4174) has a Working Capital to Net Assets ratio of 45.1% as of December 2025. Working capital of NT$1.23 Billion (current assets of NT$1.58 Billion minus current liabilities of NT$350.56 Million) is measured against net assets of NT$2.73 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 4174 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
OBI Pharma Working Capital to Net Assets (2011–2025)
This chart shows how OBI Pharma's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 45.1%, reflecting working capital of NT$1.23 Billion against net assets of NT$2.73 Billion TWD. See 4174 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for OBI Pharma (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for OBI Pharma from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 4174 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 45.1% | NT$1.23 Billion | NT$2.73 Billion | NT$1.58 Billion | NT$350.56 Million | ▼ -17.7 pp |
| 2024 | 62.8% | NT$3.03 Billion | NT$4.82 Billion | NT$3.44 Billion | NT$412.37 Million | ▲ +2.2 pp |
| 2023 | 60.6% | NT$3.00 Billion | NT$4.95 Billion | NT$3.16 Billion | NT$158.62 Million | ▼ -17.8 pp |
| 2022 | 78.4% | NT$4.81 Billion | NT$6.14 Billion | NT$5.03 Billion | NT$221.14 Million | ▲ +13.2 pp |
| 2021 | 65.3% | NT$2.53 Billion | NT$3.87 Billion | NT$2.85 Billion | NT$327.22 Million | ▼ -10.1 pp |
| 2020 | 75.4% | NT$3.65 Billion | NT$4.84 Billion | NT$3.89 Billion | NT$248.49 Million | ▼ -11.2 pp |
| 2019 | 86.6% | NT$4.51 Billion | NT$5.20 Billion | NT$4.71 Billion | NT$200.00 Million | ▲ +4.1 pp |
| 2018 | 82.5% | NT$3.69 Billion | NT$4.47 Billion | NT$3.79 Billion | NT$103.82 Million | ▼ -9.3 pp |
| 2017 | 91.8% | NT$4.64 Billion | NT$5.06 Billion | NT$4.71 Billion | NT$68.65 Million | ▲ +30.4 pp |
| 2016 | 61.4% | NT$3.78 Billion | NT$6.16 Billion | NT$3.88 Billion | NT$97.46 Million | ▲ +30.3 pp |
| 2015 | 31.1% | NT$2.23 Billion | NT$7.18 Billion | NT$2.36 Billion | NT$127.00 Million | ▼ -30.8 pp |
| 2014 | 61.9% | NT$893.11 Million | NT$1.44 Billion | NT$937.35 Million | NT$44.24 Million | ▼ -3.6 pp |
| 2013 | 65.4% | NT$1.26 Billion | NT$1.93 Billion | NT$1.30 Billion | NT$41.46 Million | ▼ -23.2 pp |
| 2012 | 88.6% | NT$735.41 Million | NT$829.77 Million | NT$779.82 Million | NT$44.40 Million | ▲ +0.4 pp |
| 2011 | 88.2% | NT$448.51 Million | NT$508.44 Million | NT$462.78 Million | NT$14.27 Million | — |